BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 28101687)

  • 1. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concepts in in vivo siRNA delivery for cancer therapy.
    Gondi CS; Rao JS
    J Cell Physiol; 2009 Aug; 220(2):285-91. PubMed ID: 19391103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference in mammalian cell systems.
    Lochmatter D; Mullis PE
    Horm Res Paediatr; 2011; 75(1):63-9. PubMed ID: 21252559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combinatorial RNAi and its application in cancer gene therapy].
    Fei LN; Wang QZ; Xu RA
    Yao Xue Xue Bao; 2012 May; 47(5):573-9. PubMed ID: 22811998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA, miRNA, and shRNA: in vivo applications.
    Pushparaj PN; Aarthi JJ; Manikandan J; Kumar SD
    J Dent Res; 2008 Nov; 87(11):992-1003. PubMed ID: 18946005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potentials of Noncoding RNAs: Targeted Delivery of ncRNAs in Cancer Cells.
    Liu Y; Wang J
    Adv Exp Med Biol; 2016; 927():429-58. PubMed ID: 27376745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
    Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
    Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming.
    Yang D; Sun L; Li Z; Gao P
    Adv Exp Med Biol; 2016; 927():191-215. PubMed ID: 27376736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi and miRNA in viral infections and cancers.
    Mollaie HR; Monavari SH; Arabzadeh SA; Shamsi-Shahrabadi M; Fazlalipour M; Afshar RM
    Asian Pac J Cancer Prev; 2013; 14(12):7045-56. PubMed ID: 24460249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference--a silent but an efficient therapeutic tool.
    Ramachandran PV; Ignacimuthu S
    Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intron-mediated RNA interference, intronic microRNAs, and applications.
    Ying SY; Chang CP; Lin SL
    Methods Mol Biol; 2010; 629():205-37. PubMed ID: 20387152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference and cancer therapy.
    Wang Z; Rao DD; Senzer N; Nemunaitis J
    Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.
    Farra R; Grassi M; Grassi G; Dapas B
    World J Gastroenterol; 2015 Aug; 21(30):8994-9001. PubMed ID: 26290628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.
    Fujimoto I; Takei Y
    Ther Deliv; 2014 Apr; 5(4):369-71. PubMed ID: 24856162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.